Research Leadership Award

Nominations Are closed for 2020.

To nominate an individual for the Research Leadership award, click HERE.

The award will be presented at the annual Meeting of the Minds, this year being held virtually. Recipients will have the opportunity to present their work as speakers of the conference. 

This award recognizes an individual who has demonstrated leadership and contributed significantly to advancing Crohn's and colitis research in Canada and has made an exceptional leadership contribution to the mission of Crohn’s and Colitis Canada. 

Nominated by their fellow scientists, recipients of the Research Leadership Award have made an exceptional contribution to Crohn’s and Colitis Canada’s Promise to cure Crohn’s disease and ulcerative colitis and improve the lives of children and adults living with these chronic diseases.

Nomination criteria: 

IBD scientists and researchers in Canada are eligible to be nominated. Nominations can be submitted by fellow scientists and IBD researchers. 

Submitting a Nomination

Nominees must complete the online application form below. Please note, applications are no longer being accepted via email or mail. If you encounter any difficulties with the online application forms, please contact research@crohnsandcolitis.ca

To nominate an individual for the Research Leadership award, click HERE.

Past Winners include:

2019      Dr. Charles Bernstein, Winnipeg, MB
2018      Dr. Laura Sly, Vancouver, BC

Contact information 

If you have any questions about Crohn's and Colitis Canada grant programs or awards, please do not hesitate to connect with us. Direct your questions to:

Research Grants Administrator
Telephone: (416) 920-5035 ext. 252
Email: research@crohnsandcolitis.ca 

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest